Extracellular matrix in obesity - cancer interactions

Area of Science:

• Biomedical Science
• Oncology
• Metabolic Disorders

Background:

• Obesity is a risk factor for type 2 diabetes, hypertension, and cancers.
• Obesity triggers inflammation, affecting the extracellular matrix (ECM) via cytokines like IGFs, leptin, and sex hormones.
• Connective tissue cells, fibroblasts, and macrophages exacerbate obesity-related inflammation through growth factors like VEGF, EGF, and TGF-β.

Purpose of the Study:

• To explore the intricate relationship between obesity, the extracellular matrix (ECM), and cancer progression.
• To elucidate the role of chemical mediators and cellular components in obesity-associated tumorigenesis.
• To highlight the therapeutic potential of understanding ECM biology in combating obesity-related pathologies.

Main Methods:

• Literature review and synthesis of existing research on obesity, ECM, and cancer.
• Analysis of signaling pathways involving cytokines, growth factors, and ECM components.
• Examination of specific examples like breast cancer in postmenopausal women.

Main Results:

• Obesity-induced inflammation and altered ECM composition, including aberrant expression of matrix metalloproteinases and matricellular proteins (thrombospondins, SPARC, CCN), are linked to tumor growth.
• Mediators such as transforming growth factor-beta (TGF-β) play a dual role in normal physiology and cancer.
• Dysregulation of ECM components and hormonal factors in obesity contributes to neoplastic processes, particularly in postmenopausal breast cancer.

Conclusions:

• The interplay between obesity, inflammation, and the ECM significantly influences cancer development and progression.
• Specific ECM components and their modulators, like matricellular proteins, exhibit complex roles in cancer.
• Targeting ECM biology presents a promising avenue for developing therapeutics against obesity-related cancers and other pathologies.